Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Acute myeloid leukemia in the elderly is characterized by a distinct genetic and epigenetic landscape

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

References

  1. Juliusson G . Older patients with acute myeloid leukemia benefit from intensive chemotherapy: an update from the Swedish Acute Leukemia Registry. Clin Lymphoma Myeloma Leuk 2011; 11: S54–S59.

    Article  Google Scholar 

  2. Hulegärdh E, Nilsson C, Lazarevic V, Garelius H, Antunovic P, Rangert Derolf Å et al. Characterization and prognostic features of secondary acute myeloid leukemia in a population-based setting: a report from the Swedish Acute Leukemia Registry. Am J Hematol 2015; 90: 208–214.

    Article  Google Scholar 

  3. Lazarevic V, Hörstedt A-S, Johansson B, Antunovic P, Billström R, Derolf A et al. Incidence and prognostic significance of karyotypic subgroups in older patients with acute myeloid leukemia: the Swedish population-based experience. Blood Cancer J 2014; 4: e188.

    Article  CAS  Google Scholar 

  4. Tsai C-H, Hou H-A, Tang J-L, Liu C-Y, Lin C-C, Chou W-C et al. Genetic alterations and their clinical implications in older patients with acute myeloid leukemia. Leukemia 2016; 30: 1485–1492.

    Article  CAS  Google Scholar 

  5. Büchner T, Berdel WE, Haferlach C, Haferlach T, Schnittger S, Müller-Tidow C et al. Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: a study by the German Acute Myeloid Leukemia Cooperative Group. J Clin Oncol 2009; 27: 61–69.

    Article  Google Scholar 

  6. Metzeler KH, Herold T, Rothenberg-Thurley M, Amler S, Sauerland MC, Görlich D et al. Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia. Blood 2016; 128: 686–698.

    Article  CAS  Google Scholar 

  7. Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med 2013; 368: 2059–2074.

    Article  Google Scholar 

  8. Metzeler KH, Becker H, Maharry K, Radmacher MD, Kohlschmidt J, Mrózek K et al. ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category. Blood 2011; 118: 6920–6929.

    Article  CAS  Google Scholar 

  9. Chou WC, Chou SC, Liu CY, Chen CY, Hou HA, Kuo YY et al. TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics. Blood 2011; 118: 3803–3810.

    Article  CAS  Google Scholar 

  10. Greif PA, Konstandin NP, Metzeler KH, Herold T, Pasalic Z, Ksienzyk B et al. RUNX1 mutations in cytogenetically normal acute myeloid leukemia are associated with a poor prognosis and up-regulation of lymphoid genes. Haematologica 2012; 97: 1909–1915.

    Article  CAS  Google Scholar 

  11. Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik V, Paschka P, Roberts N et al. Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med 2016; 374: 2209–2221.

    Article  CAS  Google Scholar 

  12. Yoshida K, Sanada M, Shiraishi Y, Nowak D, Nagata Y, Yamamoto R et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 2011; 478: 64–69.

    Article  CAS  Google Scholar 

  13. Guryanova OA, Shank K, Spitzer B, Luciani L, Koche RP, Garrett-Bakelman FE et al. DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling. Nat Med 2016; 22: 1488–1495.

    Article  CAS  Google Scholar 

  14. Figueroa ME, Skrabanek L, Li Y, Jiemjit A, Fandy TE, Paietta E et al. MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation. Blood 2009; 114: 3448–3458.

    Article  CAS  Google Scholar 

  15. Lin Q, Wagner W . Epigenetic aging signatures are coherently modified in cancer. PLoS Genet 2015; 11: e1005334.

    Article  Google Scholar 

Download references

Acknowledgements

We thank Liliana H Mochmann for the critical reading of the manuscript. This study was supported by Else Kröner-Fresenius-Stiftung (2013A153), the German Cancer Consortium (Deutsches Konsortium fur Translationale Krebsforschung DKTK, Heidelberg, Germany), the Deutsche Krebshilfe (Mildred Scheel Stiftungsprofessur, CDB) and the Deutsche Forschungsgemeinschaft (DFG EXC 1003, WEB). PS was supported by the Berlin School of Integrative Oncology (BSIO).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C D Baldus.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on the Leukemia website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Silva, P., Neumann, M., Schroeder, M. et al. Acute myeloid leukemia in the elderly is characterized by a distinct genetic and epigenetic landscape. Leukemia 31, 1640–1644 (2017). https://doi.org/10.1038/leu.2017.109

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2017.109

This article is cited by

Search

Quick links